CME Group Inc. $CME Stock: Ilmarinen Mutual Pension Insurance Co Increases Stake

Ilmarinen Mutual Pension Insurance Co boosted its position in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 29.8% in the third quarter, Holdings Channel reports. The fund owned 94,238 shares of the financial services provider’s stock after acquiring an additional 21,627 shares during the period. Ilmarinen Mutual Pension Insurance Co’s holdings in CME Group were worth $24,688,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently bought and sold shares of the company. BlackRock Inc. bought a new stake in CME Group during the second quarter valued at about $6,749,965,000. Bank of New York Mellon Corp acquired a new stake in shares of CME Group in the second quarter valued at about $867,313,000. Alphabet Inc. bought a new position in shares of CME Group in the second quarter worth about $769,376,000. Mitsubishi UFJ Asset Management Co. Ltd. bought a new position in shares of CME Group in the second quarter worth about $629,771,000. Finally, Bank of America Corp DE bought a new position in shares of CME Group in the second quarter worth about $622,679,000. 87.75% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on the company. Barclays boosted their price objective on CME Group from $281.00 to $321.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 22nd. Piper Sandler restated an “overweight” rating and set a $330.00 target price (up from $295.00) on shares of CME Group in a research note on Thursday, October 22nd. JPMorgan Chase & Co. raised CME Group from an “underweight” rating to an “overweight” rating and set a $367.00 target price on the stock in a report on Thursday, October 22nd. Morgan Stanley lifted their price target on CME Group from $337.00 to $359.00 and gave the stock an “overweight” rating in a research report on Thursday, October 22nd. Finally, TD Cowen lifted their price target on CME Group from $292.00 to $300.00 and gave the stock a “buy” rating in a research report on Monday, October 5th. Ten research analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $314.44.

Read Our Latest Stock Analysis on CME Group

CME Group Price Performance

Shares of CME Group stock opened at $307.54 on Friday. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a fifty-two week low of $218.31 and a fifty-two week high of $329.16. The firm has a fifty day moving average price of $289.43 and a two-hundred day moving average price of $282.08. The company has a market cap of $110.08 billion, a PE ratio of 25.23, a price-to-earnings-growth ratio of 3.90 and a beta of 0.15.

CME Group (NASDAQ:CME – Get Free Report) last posted its quarterly earnings results on Wednesday, October 21st. The financial services provider reported $3.02 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.99 by $0.03. CME Group had a net margin of 63.33% and a return on equity of 16.23%. The company had revenue of $1.74 billion for the quarter, compared to analyst estimates of $1.71 billion. During the same period last year, the business posted $2.68 EPS. The business’s quarterly revenue was up 10.6% on a year-over-year basis. Analysts expect that CME Group Inc. will post 12.36 EPS for the current year.

CME Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, December 30th. Investors of record on Friday, December 11th will be paid a $1.30 dividend. This represents a $5.20 annualized dividend and a dividend yield of 1.7%. The ex-dividend date is Friday, December 11th. CME Group’s dividend payout ratio (DPR) is presently 42.66%.

Insiders Place Their Bets

In related news, Director Howard Siegel sold 2,000 shares of the business’s stock in a transaction dated Monday, November 2nd. The stock was sold at an average price of $303.00, for a total transaction of $606,000.00. Following the transaction, the director directly owned 19,873 shares in the company, valued at $6,021,519. The trade was a 9.14% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Julie Winkler sold 10,079 shares of the business’s stock in a transaction dated Monday, November 2nd. The shares were sold at an average price of $305.15, for a total value of $3,075,606.85. Following the transaction, the insider owned 21,482 shares in the company, valued at $6,555,232.30. This represents a 31.93% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 61,166 shares of company stock valued at $18,276,512 in the last quarter. 0.30% of the stock is currently owned by insiders.

Key Stories Impacting CME Group

Investors following CME have been watching these stories:

  • Positive Sentiment: CME reported that XRP and Micro XRP futures generated $81.2 billion in notional volume across roughly 18 months, averaging $216 million per day through mid-November. Strong activity may support transaction and clearing revenue. Article
  • Positive Sentiment: The company announced the first trade in its wind power contracts, extending its product lineup and potentially opening another market for trading and risk management. Article
  • Neutral Sentiment: A report highlights exchange operators’ potential exposure to AI-driven trading, but provides no specific new CME business or financial update. Article

About CME Group

(Free Report)

CME Group operates a global marketplace for derivatives and other financial products. Through its exchanges—CME, CBOT, NYMEX and COMEX—it offers futures and options contracts tied to interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The company also provides clearing and settlement services, market data and related products. Its electronic trading platform, CME Globex, supports access to its markets by participants around the world, alongside its open-outcry and privately negotiated trading services.

Recommended Stories

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.